Related Experiment Videos
Genes and chromosomes in chronic B-cell leukemia
1Cytogenetic and Molecular Oncology Unit, Christchurch Hospital, New Zealand.
Cancer Genetics and Cytogenetics
|March 1, 1997
Summary
Cytogenetic analysis reveals common chromosome abnormalities in chronic B-cell leukemia (B-CLL), including trisomy 12 and 13q14 alterations. These genetic changes are secondary events impacting disease progression and patient survival.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Chronic B-cell leukemia (B-CLL) is characterized by chromosomal abnormalities.
- Cytogenetic analysis and molecular techniques detect these alterations, influencing disease characteristics.
Purpose of the Study:
- To investigate the incidence and types of chromosome abnormalities in B-CLL.
- To understand the role of these abnormalities in disease progression and prognosis.
Main Methods:
- Cytogenetic analysis
- Fluorescence in situ hybridization (FISH)
- Molecular techniques
- Immunophenotyping
Main Results:
- 50% of B-CLL patients exhibit chromosome abnormalities; FISH and molecular methods reveal higher rates.
- Trisomy 12 and 13q14 deletions/translocations are most common but lack identified genes.
- These abnormalities are secondary events in B-CLL.
- Trisomy 12 correlates with poor prognosis, advanced disease, and atypical morphology.
- p53 mutations (10-15%) are linked to advanced disease, treatment resistance, and poor survival.
Conclusions:
- Chromosome abnormalities are frequent in B-CLL and play a role in disease pathogenesis.
- Further research is needed to identify genes involved in B-CLL chromosomal alterations.
- Specific abnormalities like trisomy 12 and p53 mutations are critical prognostic markers.